Related Experiment Video

Updated: May 15, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Overview of invasive fungal infections

Nina L Tuite1, Katrina Lacey

  • 1Molecular Diagnostics Research Group, National University of Ireland, Galway, Ireland. ninatuite@gmail.com

Methods in Molecular Biology (Clifton, N.J.)
|January 9, 2013
PubMed

Insights

Invasive fungal infections (IFIs) are increasing, particularly in immunocompromised patients. Early diagnosis and effective antifungal therapy are crucial for survival and reducing severe health impacts.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Rising incidence of invasive fungal infections (IFIs) over the past two decades.
  • IFIs disproportionately affect immunocompromised individuals, including transplant recipients and AIDS patients.
  • Emergence of antifungal resistance in opportunistic and novel fungal pathogens presents a significant clinical challenge.

Purpose of the Study:

  • To highlight the increasing challenge posed by invasive fungal infections.
  • To emphasize the critical need for advancements in early diagnosis and effective antifungal treatment strategies.
  • To discuss the evolving epidemiological landscape of IFIs in response to antifungal therapies.

Main Methods:

  • Review of current literature on IFI epidemiology and treatment.
  • Analysis of trends in IFI incidence and antifungal resistance.
  • Evaluation of diagnostic and therapeutic advancements in managing IFIs.

Main Results:

  • Significant increase in IFI incidence, especially in vulnerable populations.
  • Growing prevalence of fungal infections resistant to standard antifungal agents.
  • Demonstrated improvements in diagnostic accuracy and therapeutic efficacy for IFIs.

Conclusions:

  • Early and accurate diagnosis coupled with appropriate antifungal therapy is vital for patient survival.
  • Changes in antifungal drug administration have influenced the epidemiological profile of IFIs.
  • Effective management of IFIs is essential to mitigate morbidity, mortality, and healthcare costs.

More Related Videos

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

Related Concept Videos

Overview of Fungi01:29

Overview of Fungi

Fungi are a diverse group of eukaryotes more closely related to animals than other eukaryotes. Fungal cell walls comprise chitin, a polysaccharide that provides structural strength, and glucans, which contribute to flexibility and integrity. Other polysaccharides, such as mannans and galactosans, may supplement or replace chitin in some fungi. These adaptations, along with their preference for acidic environments and tolerance for high osmotic pressure, enable fungi to thrive in various...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...